TANGA; MARY J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for TANGA; MARY J..The latest application filed is for "use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic pain".

Company Profile

0.7.8

TANGA; MARY J. - Los Altos CA
Tanga; Mary J. - Menlo Park CA
Tanga; Mary J. - Los Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine And Other Stereoisomeric Dehydro And Hydroxylated Metabolites Of (r,s)-ketamine In The Treatment Of Depression And Neuropathic Pain App 20200360393 - WAINER; IRVING W. ; et al.	2020-11-19
Use Of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine And Other Stereoisomeric Dehydro And Hydroxylated Metabolites Of (r,s)- Ketamine In The Treatment Of Depression And Neuropathic Pain App 20180098993 - WAINER; IRVING W. ; et al.	2018-04-12
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain Grant 9,867,830 - Wainer , et al. January 16, 2	2018-01-16
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain Grant 9,650,352 - Wainer , et al. May 16, 2	2017-05-16
Use Of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine And Other Stereoisomeric Dehydro And Hydroxylated Metabolites Of (r,s)- Ketamine In The Treatment Of Depression And Neuropathic Pain App 20170049780 - WAINER; IRVING W. ; et al.	2017-02-23
The Use Of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine And Other Stereoisomeric Dehydro And Hydroxylated Metabolites Of (r,s)- Ketamine In The Treatment Of Depression And Neuropathic Pain App 20140296241 - Wainer; Irving W. ; et al.	2014-10-02
Arsenical Fluorescent Agents and Assays App 20140162309 - Beaulieu; Laura Ellen Downs ; et al.	2014-06-12
Arsenical fluorescent agents and assays Grant 8,664,009 - Beaulieu , et al. March 4, 2	2014-03-04
Compounds for activating TGF-beta signaling Grant 8,410,138 - Wyss-Coray , et al. April 2, 2	2013-04-02
Compounds For Activating Tgf-beta Signaling App 20120095000 - Wyss-Coray; Anton ; et al.	2012-04-19
Compounds for activating TGF-.beta. signaling Grant 8,097,645 - Wyss-Coray , et al. January 17, 2	2012-01-17
Arsenical Fluorescent Agents and Assays App 20110229929 - Beaulieu; Laura Ellen Downs ; et al.	2011-09-22
Compounds For Activating Tgf-beta Signaling App 20090143394 - Wyss-Coray; Anton ; et al.	2009-06-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.